Hasil Pencarian - Anna Olsson
- Menampilkan 1 - 17 hasil dari 17
-
1
-
2
Immune checkpoint inhibitor-induced cholangitis—a three-case series oleh Simon Gray, Nuria Santamaria, Anna Olsson-Brown
Diterbitkan 2024-07-01
Artikel -
3
-
4
A case of immunotherapy-induced thyroiditis oleh George Pears, Abhishek Mahajan, Anna Olsson-Brown, Joseph Sacco
Diterbitkan 2024-02-01
Artikel -
5
Two distinct clinical patterns of checkpoint inhibitor-induced thyroid dysfunction oleh Anna Olsson-Brown, Rosemary Lord, Joseph Sacco, Jonathan Wagg, Mark Coles, Munir Pirmohamed
Diterbitkan 2020-04-01
Artikel -
6
Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity oleh Ik Shin Chin, Aman Khan, Anna Olsson-Brown, Sophie Papa, Gary Middleton, Claire Palles
Diterbitkan 2022-12-01
Artikel -
7
-
8
MRI of the Entire Spinal Cord—Worth the While or Waste of Time? A Retrospective Study of 74 Patients with Multiple Sclerosis oleh Esben Nyborg Poulsen, Anna Olsson, Stefan Gustavsen, Annika Reynberg Langkilde, Annette Bang Oturai, Jonathan Frederik Carlsen
Diterbitkan 2021-08-01
Artikel -
9
Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights oleh David G. Gent, Nasim Ali, Anna Olsson-Brown, Gregory Y.H. Lip, David J. Wright, Rebecca Dobson
Diterbitkan 2022-11-01
Artikel -
10
Evolving cardiac biomarkers for immune checkpoint inhibitor related myocarditis in cancer patients oleh Suprateeka Talukder, Aruni Ghose, Turja Chakraborty, Anna Olsson-Brown, Sivatharshini Ramalingam, Stuart D. Rosen, Kate Young, Alexander R. Lyon, Arjun K. Ghosh
Diterbitkan 2023-12-01
Artikel -
11
T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab oleh Munir Pirmohamed, Anna Olsson-Brown, Lorenzo Ressel, Sean Hammond, Joshua Gardner, Serat-E Ali, Paul Thomson, Carol Jolly, Dan Carr, Dean Naisbitt
Diterbitkan 2021-05-01
Artikel -
12
Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls oleh Anna Olsson, Stefan Gustavsen, Thao Duy Nguyen, Margareta Nyman, Annika R. Langkilde, Tue H. Hansen, Finn Sellebjerg, Annette B. Oturai, Helle Bach Søndergaard
Diterbitkan 2021-05-01
Artikel -
13
421 Initial results of a phase 1 trial of RP2, a first in class, enhanced potency, anti-CTLA-4 antibody expressing, oncolytic HSV as single agent and combined with nivolumab in pat... oleh Anna Olsson-Brown, Joseph Sacco, Mark Middleton, Kevin Harrington, Robert Coffin, Howard Kaufman, Suzanne Thomas, Praveen Bommareddy, Francesca Aroldi, Pablo Nanclares, Lavita Menezes, Selda Samakoglu
Diterbitkan 2020-11-01Artikel -
14
507 A phase 1 clinical trial of RP2, an enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody, as a single agent and combined with nivolumab in patients with advanced s... oleh Anna Olsson-Brown, Joseph Sacco, Mark Middleton, Kevin Harrington, Robert Coffin, Andrea Pirzkall, Praveen Bommareddy, Isla Leslie, Francesca Aroldi, Pablo Nenclares, Tze Chan, Imran Saleem, Henry Castro
Diterbitkan 2021-11-01Artikel -
15
Ecological genomics in the Northern krill uncovers loci for local adaptation across ocean basins oleh Per Unneberg, Mårten Larsson, Anna Olsson, Ola Wallerman, Anna Petri, Ignas Bunikis, Olga Vinnere Pettersson, Chiara Papetti, Astthor Gislason, Henrik Glenner, Joan E. Cartes, Leocadio Blanco-Bercial, Elena Eriksen, Bettina Meyer, Andreas Wallberg
Diterbitkan 2024-08-01
Artikel -
16
Cannabis-Based Medicine for Neuropathic Pain and Spasticity—A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial oleh Julie Schjødtz Hansen, Stefan Gustavsen, Homayoun Roshanisefat, Matthias Kant, Fin Biering-Sørensen, Claus Andersen, Anna Olsson, Helene Højsgaard Chow, Nasrin Asgari, Julie Richter Hansen, Helle Hvilsted Nielsen, Rikke Middelhede Hansen, Thor Petersen, Annette Bang Oturai, Finn Sellebjerg, Eva Aggerholm Sædder, Helge Kasch, Peter Vestergaard Rasmussen, Nanna Brix Finnerup, Kristina Bacher Svendsen
Diterbitkan 2023-07-01
Artikel -
17
506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 ± nivolumab in patients with advanced solid tumors oleh Anna Olsson-Brown, Joseph Sacco, Mark Middleton, Jason Chesney, Mohammed Milhem, Kevin Harrington, Robert Coffin, Katy Tsai, Adel Samson, Bartosz Chmielowski, Ari VanderWalde, Andrea Pirzkall, Jiaxin Niu, Praveen Bommareddy, Georgia Beasley, Gino In, Terence Rhodes, Francesca Aroldi, Lavita Menezes, Tawnya Bowles, Hamid Emamekhoo, Scott Baum, Sophie Dalac-Rat, Katharina Kahler, Eva Muñoz
Diterbitkan 2021-11-01Artikel